Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Impact of target lesion coronary calcification on stent expansion.

Kobayashi Y, Okura H, Kume T, Yamada R, Kobayashi Y, Fukuhara K, Koyama T, Nezuo S, Neishi Y, Hayashida A, Kawamoto T, Yoshida K.

Circ J. 2014;78(9):2209-14.

2.

Intravascular ultrasound assessment of drug-eluting stent expansion.

de Ribamar Costa J Jr, Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, Tanaka K, Costa RA, Lui J, Na Y, Castellanos C, Biro S, Moussa I, Stone GW, Moses JW, Leon MB.

Am Heart J. 2007 Feb;153(2):297-303.

PMID:
17239693
3.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013.

4.

Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance.

Habara M, Nasu K, Terashima M, Kaneda H, Yokota D, Ko E, Ito T, Kurita T, Tanaka N, Kimura M, Ito T, Kinoshita Y, Tsuchikane E, Asakura K, Asakura Y, Katoh O, Suzuki T.

Circ Cardiovasc Interv. 2012 Apr;5(2):193-201. doi: 10.1161/CIRCINTERVENTIONS.111.965111.

5.

Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.

Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Circ Cardiovasc Interv. 2015 Feb;8(2):e001878. doi: 10.1161/CIRCINTERVENTIONS.114.001878.

6.

Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.

Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.

JACC Cardiovasc Interv. 2013 Oct;6(10):1035-45. doi: 10.1016/j.jcin.2013.05.015.

7.

Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).

Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia HM, Veldhof S, Rapoza R, Ormiston JA.

JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.

8.

Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.

Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y.

JACC Cardiovasc Interv. 2009 Dec;2(12):1240-7. doi: 10.1016/j.jcin.2009.10.006.

9.

Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.

Radu MD, Räber L, Kalesan B, Muramatsu T, Kelbæk H, Heo J, Jørgensen E, Helqvist S, Farooq V, Brugaletta S, Garcia-Garcia HM, Jüni P, Saunamäki K, Windecker S, Serruys PW.

Eur Heart J. 2014 Mar;35(12):795-807. doi: 10.1093/eurheartj/eht344.

PMID:
24132187
10.

Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.

Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Apr;28(4):705-14. doi: 10.1007/s10554-011-9896-0.

PMID:
21626042
11.

The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.

Kim JS, Ha J, Kim BK, Shin DH, Ko YG, Choi D, Jang Y, Hong MK.

JACC Cardiovasc Interv. 2014 Jun;7(6):641-51. doi: 10.1016/j.jcin.2013.12.205.

12.

Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.

Her AY, Lee BK, Shim JM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Am J Cardiol. 2010 Jun 1;105(11):1565-9. doi: 10.1016/j.amjcard.2010.01.013.

PMID:
20494663
13.

Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation.

Im E, Kim BK, Ko YG, Shin DH, Kim JS, Choi D, Jang Y, Hong MK.

Circ Cardiovasc Interv. 2014 Feb;7(1):88-96. doi: 10.1161/CIRCINTERVENTIONS.113.000797.

14.

First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.

Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F.

JACC Cardiovasc Interv. 2009 Mar;2(3):197-204. doi: 10.1016/j.jcin.2008.12.006.

15.

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation.

Radu MD, Räber L, Heo J, Gogas BD, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia HM, Windecker S, Saunamäki K, Serruys PW.

EuroIntervention. 2014 Jan 22;9(9):1085-94. doi: 10.4244/EIJV9I9A183.

16.

Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.

Räber L, Zanchin T, Baumgartner S, Taniwaki M, Kalesan B, Moschovitis A, Garcia-Garcia HM, Justiz J, Pilgrim T, Wenaweser P, Meier B, Jüni P, Windecker S.

Int J Cardiol. 2014 May 1;173(2):259-67. doi: 10.1016/j.ijcard.2014.02.036.

PMID:
24631113
17.

Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.

Vergallo R, Yonetsu T, Uemura S, Park SJ, Lee S, Kato K, Jia H, Abtahian F, Tian J, Hu S, Lee H, McNulty I, Prasad A, Yu B, Zhang S, Porto I, Biasucci LM, Crea F, Jang IK.

Am J Cardiol. 2013 Nov 1;112(9):1315-21. doi: 10.1016/j.amjcard.2013.05.076.

PMID:
23891431
18.

Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.

Chieffo A, Buchanan GL, Parodi G, Versaci F, Bianchi RM, Valenti R, Saccà S, Mongiardo A, Span S, Migliorini A, Spaccarotella C, Reimers B, Antoniucci D, Indolfi C, Ferrari A, Maehara A, Mintz GS, Colombo A.

EuroIntervention. 2014 Dec;10(8):916-23. doi: 10.4244/EIJY14M06_10.

19.

Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients.

Sanidas EA, Maehara A, Mintz GS, Kubo T, Gupta A, Apfelbaum MA, Hakim D, Moses JW, Mancini DM, Rabbani LE.

Catheter Cardiovasc Interv. 2013 Feb;81(3):429-35. doi: 10.1002/ccd.24437.

PMID:
22461357
20.

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.

Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA; ODESSA Trial Investigators..

JACC Cardiovasc Interv. 2010 May;3(5):531-9. doi: 10.1016/j.jcin.2010.02.008.

Items per page

Supplemental Content

Support Center